If participant is found to be eligible to take part in this study, participant will be assigned to a study group based on when participant joins this study. Up to 3 groups of 6 participants will be enrolled in Phase 1 of the study. Up to 25 participants who have not received treatment for AML and up to 25 participants who have previously received treatment for AML (up to 50 participants total) will be enrolled in Phase 2.